Short Interest in Bionomics Limited (NASDAQ:BNOX) Decreases By 24.9%

Bionomics Limited (NASDAQ:BNOX) was the target of a significant drop in short interest in the month of July. As of July 15th, there was short interest totalling 148,600 shares, a drop of 24.9% from the June 30th total of 198,000 shares. Based on an average daily volume of 525,900 shares, the short-interest ratio is currently 0.3 days.

Bionomics Trading Up 0.8 %

Shares of NASDAQ BNOX traded up $0.01 during midday trading on Friday, reaching $0.68. The company had a trading volume of 168,120 shares, compared to its average volume of 1,230,933. Bionomics has a one year low of $0.65 and a one year high of $6.41. The firm’s fifty day moving average price is $0.79 and its 200-day moving average price is $0.95.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reissued a “buy” rating and issued a $8.00 price objective on shares of Bionomics in a research note on Thursday, July 18th.

About Bionomics

Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder.